Kenya secures US$461.22M grant to combat HIV, TB, Malaria

 KENYA – Kenya has secured a KSH59.7 billion (US$461.22 million) grant from the Global Fund to support interventions against HIV, Tuberculosis (TB), and Malaria over the next three years.

The grant, announced in a joint statement by the Ministry of Health and the Global Fund, will contribute to achieving Universal Health Coverage through comprehensive HIV prevention, treatment and care.

Additionally, it aims to reduce malaria incidence and deaths by at least 75% by 2027.

The total grant is divided into four components: an HIV grant of US$232.58 million, a malaria grant of US$72.93 million, a TB grant of US$67.79 million, and US$34.69 million for health systems strengthening.

The new global fund will support the provision of quality care and prevention services for all people with TB, leprosy and lung diseases.

It will also seek to strengthen health systems at the facility and community level, including the procurement of essential commodities like medicines, laboratory supplies and test kits.

The fund will facilitate social support and Social Health Insurance Fund (SHIF) premiums for TB/HIV/Malaria patients to access a full SHIF benefit package, in line with the Universal Health Care agenda.

The Global Fund’s partnership with the Kenyan government has already yielded positive results.

In the TB program, the country has recorded a treatment success rate of 86% and a decline in the average positivity rate among TB presumptive cases from 7.35% in 2021 to 5.6% in March 2024.

The Malaria program has also contributed to a reduction in the national prevalence from 8.2% in 2015 to 6% in 2023.

Furthermore, the Global Fund has invested US$9.5 million (Ksh1.2 billion) in the construction, equipping and digitization of the KEMSA National Supply Chain Centre, which will enhance the supply chain, support service delivery at the primary healthcare level, and strengthen responses to pandemics and emergencies.

The Global Fund is a partnership between governments, civil society, the private sector and people affected by diseases, designed to accelerate the end of the AIDS, Tuberculosis and Malaria epidemics globally.

For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook